MK-1903, CAS [[1268882-43-4]]

Produktübersicht

• Artikelname: MK-1903, CAS [[1268882-43-4]]
• Artikelnummer: MCE-HY-107581
• Hersteller Artikelnummer: HY-107581
• Alternativnummer: MCE-HY-107581-10MMX1ML,MCE-HY-107581-100MG,MCE-HY-107581-50MG,MCE-HY-107581-10MG,MCE-HY-107581-5MG,MCE-HY-107581-25MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

MK-1903 is an orally active full agonist of GPR109a/HCAR2, with an EC50 of 12.9 nM. MK-1903 activates antilipolytic and vasodilatory pathways, reduces plasma free fatty acid levels, and induces skin flushing. MK-1903 stimulates the expression of HCAR2 protein and regulates the inflammatory response of microglia. MK-1903 prevents the enhanced firing activity of spinal nociceptive neurons. MK-1903 triggers the release of MMP-9 and the formation of NET. MK-1903 can be used in the research of dyslipidemia and neuroinflammation-based central nervous system diseases[1][2][3].

Produkteigenschaften

• Molekulargewicht: 164.16
• Reinheit: 99.68
• CAS Nummer: [1268882-43-4]
• Formel: C8H8N2O2
• Target-Kategorie: GPR109A,MMP

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound